Navigation Links
Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7
Date:12/3/2009

rial Convention Center) Poster Board III-649 Poster Session: Lymphoma: Chemotherapy, excluding Pre-Clinical Models Poster III Primary presenter: Dr. Daniel Pollyea, Stanford University

About Pharmacyclics

Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of immune mediated disease and cancer. The purpose of the company is to create a profitable business by generating income from products it develops, licenses and commercializes, either with one or several potential partners or alone as may best forward the economic interest of its stakeholders. The Company endeavors to create novel, patentable, differentiated products that have the potential to significantly improve the standard of care in the markets it serves. Presently, Pharmacyclics has four product candidates in clinical development and two product candidates in pre-clinical development. It is Pharmacyclics' business strategy to establish collaborations with large pharmaceutical and biotechnology companies for the purpose of generating present and future income in exchange for adding to their product pipelines. Pharmacyclics strives to generate collaborations that allow it to retain valuable territorial rights and simultaneously fast forward the clinical development and commercialization of its products. The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.


Contact:
Ramses Erdtmann
Vice President of Finance
Phone: 408-215-3325

SOURCE Pharmacyclics, Inc.


'/>"/>
SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
2. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
3. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
4. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
5. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
6. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
7. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
8. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
9. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
10. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
11. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... separating membrane market has witnessed robust development with the growth ... a later starter. In 2012, the size of ... with the proportion worldwide soaring to 16.3%. It is projected ... continue its growth rate by around 20% in the upcoming ... roughly RMB25 billion. An integrated membrane industrial system ...
(Date:12/17/2014)... , Dec. 17, 2014  Northstar Global ... Depository Trust Company (DTC) has made their final ... Chill on the Company,s stock effective December 15, ... common stock for depository and book entry transfer ... Company is now once again fully "DTC Eligible", ...
(Date:12/17/2014)... N.J. , Dec. 17, 2014  IGI Laboratories, ... today the closing of its offering of $125 million ... 2019 (the "Notes").  The Notes were offered and sold ... under the Securities Act of 1933, as amended (the ... a fixed rate of 3.75% per year, payable semiannually ...
Breaking Medicine Technology:Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4
... TORONTO, Dec. 20, 2011  Generex Biotechnology Corporation (OTCBB: GNBT.OB) ... the Antigen Express breast cancer vaccine did not ... Bloomberg Television,s December 16, 2011 promotional spot).  The ... of Bloomberg Television advise as to a rescheduled ...
... Pharma Corporation (OTCBB: NPHC), a biotechnology company that is ... (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the ... a Shareholder Letter on the Company,s website. ... explained Rik J. Deitsch, Chairman and CEO of ...
Cached Medicine Technology:Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment 2Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment 3Nutra Pharma Letter to Shareholders 2
(Date:12/21/2014)... Theme and plugin developers ... plugin for Final Cut Pro X entitled ProMotion. , ... more with absolute ease.” Said Christiana Austin, CEO of ... needed to easily animate their media inside FCPX.” , ... users to animate pictures, videos, logos, and more with ...
(Date:12/20/2014)... BambooIndustry.com is a professional company ... business has recently shown its new engineered bamboo flooring ... bamboo flooring models. , BambooIndustry.com’s customers come from many ... more. According to the CEO of the company, the ... in the past few years, and the demand for ...
(Date:12/20/2014)... Dress company LunaDress has recently announced its ... Christmas Sale, offering big discounts on all of its special ... idea to own a perfect wedding gown. If you have ... then come to LunaDress. Many different wedding dress styles and ... website now and enjoy the current special offer, up to ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 The Doctor’s Office ... for the better part of a decade. They’ve treated ... a better, faster healthcare alternative to the Paramus ... announce three new additions to their staff of top-notch board ... Jill Zeiger MD. These new doctors will work ...
(Date:12/20/2014)... December 20, 2014 Recently, AngelWeddingDress.com has ... Discount ”) for the coming Christmas. In the promotion, ... 80% off. , “We have something special for the ... the holiday season. Moreover, our new collections of 2015 ... are offered now at greatly discounted prices. Visit our ...
Breaking Medicine News(10 mins):Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2
... recent report in Nature Medicine had said that the ... Encephalitis in India is due to lack of preparedness ... early vaccination programs//. The encephalitis infection is spread by ... in water logged paddy fields in the monsoon seasons. ...
... in the July issue of the journal Environmental Health ... levels and age of onset of natural menopause//. ... to reflect the rate of atrophy of the ovarian ... health implications because women with early menopause are at ...
... for its miraculous properties, Herceptin, the breast cancer wonder ... British medical journal questioned its effectiveness//. ,"The ... is profoundly misleading to suggest, even rhetorically, that the ... breast cancer," the editors of The Lancet wrote in ...
... role in female mortality, second only to infanticide in Asian ... student of economics at Harvard University//, found that infanticide may ... to female ratios in many Asian countries, reports science portal ... particularly China, where some 10 to 15 percent of the ...
... a multinational company to bring a cost effective vaccine ... Minister Anbumani Ramadoss //on the occasion of National Cancer ... cancer has been instrumental behind the initiative. ... mobilizing things to implement the plan in association with ...
... that reflecting on personal values can keep neuroendocrine and ... is implicated in the development //and progression of a ... and research on the self suggest that self-affirming activities ... study, published in the November issue of the journal ...
Cached Medicine News:Health News:Herceptin Not A ‘Wonder’ Drug, Says The Lanc 2Health News:Cervical Cancer Vaccine To Be Developed In India 2
... from monofilament polypropylene, is used for hernia ... wall. The monofilaments are knitted into an ... is characterized by the extreme dimensional stabilityof ... to movements of the patient. ,The technically ...
... of the Applied Fiberoptics headlight delivers a ... six models to choose from, with both ... ranges from 15 mm to 120 mm., ... with any of our quality fiberoptic cables ...
... Orion incorporates superior optics in a durable ... fully adjustable headband, made of white molded ... the brow, directing the spot along your ... the headband position the cable diagonally over ...
... seven pounds of intelligent Pulse Oximeter ... software developed over 7 years by ... ultimate in non-invasive oxygen saturation monitoring. ... technology and sophisticated saturation sensor designs ...
Medicine Products: